Detalhe da pesquisa
1.
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma.
Br J Cancer
; 129(5): 811-818, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488446
2.
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study.
Invest New Drugs
; 32(5): 995-1004, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771350
3.
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors.
Clin Cancer Res
; 14(7): 2075-81, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18381947
4.
HDAC inhibitors and cardiac safety.
Clin Cancer Res
; 13(3): 1068; author reply 1068-9, 2007 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17289905